Blocking of MBL with the monoclonal antibody 3F8 in a mouse model decreased infarct size and fibrin deposition after myocardial ischemia/reperfusion and prevented ferric chloride–induced occlusive arterial thrombogenesis (51). This evidence concerns the gene MBL2 and myocardial ischemia.